We are live on ! Find out more
WJA

Williams Jones & Associates Portfolio holdings

AUM $4.82B
1-Year Est. Return 19.95%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+19.95%
3 Year Est. Return
+72.11%
5 Year Est. Return
+86.19%
10 Year Est. Return
AUM
$3.24B
AUM Growth
+$1.1B
Cap. Flow
+$1.04B
Cap. Flow %
32.2%
Top 10 Hldgs %
24.95%
Holding
434
New
69
Increased
208
Reduced
78
Closed
33

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$26.1M
2
SIG icon
Signet Jewelers
SIG
+$22M
3
GT icon
Goodyear
GT
+$18M
4
BX icon
Blackstone
BX
+$9.22M
5
WSM icon
Williams-Sonoma
WSM
+$7.23M

Sector Composition

Rank Sector Weight
1 Healthcare 18.82%
2 Industrials 13.57%
3 Technology 11.96%
4 Financials 11.11%
5 Communication Services 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
326
Applied Materials
AMAT
$411B
$223K 0.01%
+9,298
New +$205K
XEL icon
327
Xcel Energy
XEL
$48.5B
$219K 0.01%
4,900
ZBH icon
328
Zimmer Biomet
ZBH
$18.8B
$219K 0.01%
+1,875
New +$212K
BBBY
329
DELISTED
Bed Bath & Beyond Inc
BBBY
$217K 0.01%
5,030
+450
+10% +$20.4K
STAA icon
330
STAAR Surgical
STAA
$1.21B
$213K 0.01%
38,610
-2,000
-5% -$12.9K
KHC icon
331
Kraft Heinz
KHC
$31.3B
$207K 0.01%
+2,337
New +$192K
TT icon
332
Trane Technologies
TT
$101B
$206K 0.01%
+3,230
New +$208K
MPC icon
333
Marathon Petroleum
MPC
$89.6B
$205K 0.01%
+5,400
New +$198K
PBCT
334
DELISTED
People's United Financial Inc
PBCT
$194K 0.01%
+13,233
New +$205K
MDXG icon
335
MiMedx Group
MDXG
$622M
$164K 0.01%
20,500
FIG
336
DELISTED
Fortress Investment Group Llc
FIG
$159K ﹤0.01%
+36,000
New +$175K
BNBX
337
DELISTED
BNB PLUS CORP
BNBX
0
LCTX icon
338
Lineage Cell Therapeutics
LCTX
$277M
$158K ﹤0.01%
69,094
VHC icon
339
VirnetX Holding Corp
VHC
$56.8M
$152K ﹤0.01%
1,895
-62
-3% -$5.68K
HIX
340
Western Asset High Income Fund II
HIX
$350M
$149K ﹤0.01%
21,500
VLY icon
341
Valley National Bancorp
VLY
$8.02B
$128K ﹤0.01%
+14,000
New +$131K
IGD
342
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$516M
$121K ﹤0.01%
17,500
ETY icon
343
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.32B
$112K ﹤0.01%
+10,800
New +$113K
OPK icon
344
Opko Health
OPK
$978M
$106K ﹤0.01%
11,300
+8,800
+352% +$89.4K
TK icon
345
Teekay
TK
$1.03B
$103K ﹤0.01%
14,500
BDJ icon
346
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.73B
$95K ﹤0.01%
+12,000
New +$91.7K
SGMO
347
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$62K ﹤0.01%
+10,750
New +$68.5K
RGN
348
DELISTED
REGENERX BIOPHARMACEUTICALS
RGN
$51K ﹤0.01%
+110,000
New +$51K
GLMD icon
349
Galmed Pharmaceuticals
GLMD
$4.83M
$45K ﹤0.01%
+56
New +$52.9K
SGYP
350
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$42K ﹤0.01%
+11,000
New +$37.3K

Similar funds

Williams Jones & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, Williams Jones & Associates held 434 positions worth $3.24B, up 51% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Williams Jones & Associates deployed $1.04B of net new capital in Q2 2016, opening 69 new positions and adding to 208 existing holdings. Its largest new stake was Idexx Laboratories: 657,531 shares worth $61.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was CVS Health, an estimated $26.1M trimmed.

  • Williams Jones & Associates's largest Q2 2016 buy was Idexx Laboratories: 657,531 shares worth $61.1M.
  • Williams Jones & Associates added most to Visa in Q2 2016, an estimated $85M increase.
  • Williams Jones & Associates's biggest Q2 2016 reduction was CVS Health, cutting an estimated $26.1M.
  • Williams Jones & Associates fully exited Signet Jewelers in Q2 2016, selling an estimated $22M.
  • Williams Jones & Associates's ten largest holdings make up 25% of its $3.24B portfolio in Q2 2016.
  • Williams Jones & Associates opened 69 new positions and closed 33 in Q2 2016.
  • Williams Jones & Associates's portfolio value rose 51% quarter-over-quarter to $3.24B.

Based on Williams Jones & Associates's 13F filing for Q2 2016, filed 15 Aug 2016.